These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842 [TBL] [Abstract][Full Text] [Related]
4. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait. Al-Baqsami ZF; Ahmad S; Khan Z Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126 [TBL] [Abstract][Full Text] [Related]
5. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure. Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170 [TBL] [Abstract][Full Text] [Related]
6. Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities. Lott TJ; Frade JP; Lyon GM; Iqbal N; Lockhart SR Med Mycol; 2012 Feb; 50(2):136-42. PubMed ID: 21838617 [TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
9. Multilocus Sequence Typing (MLST) Genotypes of Byun SA; Won EJ; Kim MN; Lee WG; Lee K; Lee HS; Uh Y; Healey KR; Perlin DS; Choi MJ; Kim SH; Shin JH Front Microbiol; 2018; 9():1523. PubMed ID: 30057573 [No Abstract] [Full Text] [Related]
10. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259 [TBL] [Abstract][Full Text] [Related]
12. Implication of genotypes for prognosis of Candida glabrata bloodstream infections. Chen PY; Huang YS; Chuang YC; Wang JT; Sheng WH; Chen YC; Chang SC J Antimicrob Chemother; 2024 Aug; 79(8):2008-2016. PubMed ID: 38906829 [TBL] [Abstract][Full Text] [Related]
13. Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of Arastehfar A; Daneshnia F; Zomorodian K; Najafzadeh MJ; Khodavaisy S; Zarrinfar H; Hagen F; Zare Shahrabadi Z; Lackner M; Mirhendi H; Salehi M; Roudbary M; Pan W; Kostrzewa M; Boekhout T Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30936110 [TBL] [Abstract][Full Text] [Related]
14. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843 [TBL] [Abstract][Full Text] [Related]
15. Candidemia surveillance in Iowa: emergence of echinocandin resistance. Matsumoto E; Boyken L; Tendolkar S; McDanel J; Castanheira M; Pfaller M; Diekema D Diagn Microbiol Infect Dis; 2014 Jun; 79(2):205-8. PubMed ID: 24666704 [TBL] [Abstract][Full Text] [Related]
16. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937 [TBL] [Abstract][Full Text] [Related]
18. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. Pfaller MA; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Diekema DJ J Clin Microbiol; 2009 Oct; 47(10):3185-90. PubMed ID: 19656983 [TBL] [Abstract][Full Text] [Related]
19. Mating genotypes and susceptibility profiles of clinical isolates of Candida glabrata from Turkey. Kaplan E; Aktaş D; Önder Ş; Metin B; Döğen A; Oz Y; Ilkit M Mycoses; 2019 Sep; 62(9):796-802. PubMed ID: 31134666 [TBL] [Abstract][Full Text] [Related]
20. Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Misas E; Seagle E; Jenkins EN; Rajeev M; Hurst S; Nunnally NS; Bentz ML; Lyman MM; Berkow E; Harrison LH; Schaffner W; Markus TM; Pierce R; Farley MM; Chow NA; Lockhart SR; Litvintseva AP J Clin Microbiol; 2024 Feb; 62(2):e0114023. PubMed ID: 38265207 [No Abstract] [Full Text] [Related] [Next] [New Search]